Acadia Healthcare Company, Inc.

What they do

Acadia operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), residential treatment centers, and outpatient behavioral healthcare services. As of December 31, 2025, it had over 12,500 beds in 277 facilities. Revenue comes from patient care services reimbursed by government programs (Medicare/Medicaid) and third-party payors.

Revenue drivers

• Acute Inpatient Psychiatric Facilities — Largest segment, generating $494.6 million in Q2 2026, roughly 57% of total revenue, flat year-over-year.
• Comprehensive Treatment Facilities — Generated $141.2 million in Q2 2026, roughly 16% of revenue, flat year-over-year.
• Specialty Treatment Facilities — Generated $133.5 million in Q2 2026, roughly 15% of revenue, down 8% year-over-year.
• Residential Treatment Facilities — Generated $96.5 million in Q2 2026, roughly 11% of revenue, up 12% year-over-year.

Recent performance

Q2 2026 revenue was $865.8 million, approximately flat versus the prior year, but up 2.8% after normalizing for supplemental payment program revenue. Net income attributable to Acadia was $10.9 million ($0.12 per diluted share), down from $30.1 million ($0.33) in Q2 2025. Adjusted EBITDA was $149.2 million versus $201.8 million, impacted by a $28.6 million PLGL reserve adjustment and a $26.1 million Florida supplemental payment benefit. Operating cash flow was $162.1 million, and capital expenditures were $38.6 million.

Strategy

Management focuses on five growth pathways: expansions of existing facilities, joint venture partnerships, de novo facilities, acquisitions, and expansion across the continuum of care. In 2025, the company added 1,089 beds, including 778 from five joint-venture facilities with partners like Henry Ford Health and Geisinger Health, and opened 15 CTCs. Recent priorities include ramping occupancy at newer facilities and generating strong free cash flow.

Risks

• Regulatory and governmental investigations — Internal or governmental investigations, whistleblower lawsuits, and regulatory actions could materially affect operations and financial results.
• Reimbursement rate reductions — Potential cuts to Medicare/Medicaid payment rates or changes to supplemental payment programs (e.g., Florida, Tennessee) could reduce revenue.
• Labor shortages and turnover — Competition for psychiatrists, nurses, and other staff could increase labor costs and reduce profitability.
• High self-insured retention — The company carries a large self-insured retention, exposing it to significant uninsured losses and premium increases.

Outlook

Management updated full-year 2026 financial and cash flow guidance, citing solid Q2 performance and progress on key priorities. They expect to build on their leadership position by continuing to open new facilities and ramp occupancy at recently opened sites. No specific numeric guidance was provided in the excerpts.